GeoVax and Leidos Enter into a Collaboration Agreement on Immunotherapy Research Program
19 nov. 2018 09h00 HE
|
GeoVax, Inc.
Combined Technologies May Yield Therapies for Multiple Cancer Indications ATLANTA, GA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology...